BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lessons Learned from COVID-19 Vaccine Trials

IQVIA Institute releases report on Lessons Learned from COVID-19 Vaccine Trials Solutions for you to dri...

April 28, 2022 | News

ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U.S

MVR-T3011, ImmVira's proprietary 3-in-1oncolytic herpes simplex virus ("oHSV"), is a novel genetically engineered oHSV which aims to achieve the ...

April 20, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

April 14, 2022 | News

TauRx's late-stage clinical trial reaches new milestone

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed treatment in t...

April 14, 2022 | News

Symbiance announces the launch of SimpleStats, an application for statistical analysis and reporting of clinical data

Symbiance announced the launch of its Artificial Intelligence (AI) powered product SimpleStats. This launch reflects Symbiance's focus to address the indus...

March 31, 2022 | News

New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer

The X-Cancer's investigator-led trial of SAR-bisPSMA in known or suspected prostate cancer (X-Calibur) is a Phase I/II IIT in up to 150 patients at the Uro...

March 25, 2022 | News

Singleron Acquires Proteona

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...

March 08, 2022 | News

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...

February 28, 2022 | News

X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...

February 10, 2022 | News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...

January 18, 2022 | News

Clario and XingImaging expand partnership to deliver PET imaging clinical trials in China

Clario, formerly ERT and Bioclinica, and XingImaging joined forces in 2018 to support multi-center clinical trials requiring PET for eligibility and drug e...

January 12, 2022 | News

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Merck, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufac...

January 07, 2022 | News

NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus

NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces the first stage in its development project t...

January 07, 2022 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

December 28, 2021 | News

Stay Connected